Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

469
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
469
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

4.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
Structure and Function of Platelets01:18

Structure and Function of Platelets

997
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
997
Introduction to Hemostasis01:05

Introduction to Hemostasis

5.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.7K
Disorders of Hemostasis01:24

Disorders of Hemostasis

710
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
710

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epigenome-wide association analysis of prenatal organophosphate ester flame retardant exposure in maternal blood implicates maternal immune and neuronal epigenetic alterations.

Environment international·2026
Same author

Association of Digoxin Use at Norwood Discharge with Fontan Completion: A Study from the Pediatric Heart Network Public Dataset.

medRxiv : the preprint server for health sciences·2026
Same author

Integrated surveillance resolves Darién paradox of Oropouche virus emergence in Panama's migration corridor.

Research square·2026
Same author

Portable hepatitis C virus RNA extraction and stabilization using low-cost lab-on-a-chip style components with shelf stable reagents.

Sensors and actuators. B, Chemical·2026
Same author

Immunological imprinting shapes the cross-reactive antibody responses to the KP.2 and LP.8.1 vaccine doses.

bioRxiv : the preprint server for biology·2026
Same author

Macroscale and microscale mechanical and biochemical properties of the equine superficial digital flexor tendon are regionally dependent.

American journal of veterinary research·2026

Related Experiment Video

Updated: Jun 6, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

181

Autoantibodies immuno-mechanically modulate platelet contractile force and bleeding risk.

Oluwamayokun Oshinowo1,2,3,4,5, Renee Copeland1,2,3,4,5, Anamika Patel6

  • 1The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.

Nature Communications
|November 25, 2024
PubMed
Summary

Low single platelet contraction force in immune thrombocytopenia (ITP) serves as a novel biomarker for bleeding risk. This discovery links cellular mechanics and immunology for diagnostic and therapeutic advancements.

More Related Videos

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

7.6K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

790

Related Experiment Videos

Last Updated: Jun 6, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

181
A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

7.6K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

790

Area of Science:

  • Mechanobiology
  • Immunology
  • Integrin Biology
  • Disease Pathophysiology

Background:

  • Altered mechanotransduction is a proposed, yet under-evidenced, mechanism in disease.
  • Immune thrombocytopenia (ITP) is an autoantibody-mediated platelet disorder lacking reliable bleeding risk biomarkers.

Purpose of the Study:

  • Introduce "single cell immuno-mechanical modulation" linking immunology and cellular mechanics.
  • Investigate platelet mechanics as a biomarker for bleeding risk in pediatric ITP patients.

Main Methods:

  • Utilized micropatterned hydrogel-laden coverslips for clinical mechanobiology studies.
  • Employed standard fluorescence microscopy to analyze single platelet contraction force.
  • Studied pediatric ITP patients (n=53) and healthy controls.

Main Results:

  • Low single platelet contraction force identified as a physics-based biomarker for bleeding in pediatric ITP (92.3% sensitivity, 90% specificity).
  • Autoantibodies and monoclonal antibodies alter cell force by stabilizing integrins in specific conformations.
  • Demonstrated immuno-mechanical modulation's role in antibody-induced mechanotransduction alterations.

Conclusions:

  • Single cell immuno-mechanical modulation provides a framework for understanding antibody-driven disease pathophysiology.
  • Platelet contraction force is a promising biomarker for predicting bleeding risk in ITP.
  • This phenomenon offers potential for controlling cellular mechanics in research, diagnostics, and therapeutics.